drugset / Trial / NCT04895631

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

NCT04895631

Phase 3 Completed 139 enrolled Thomas Hope
NaSingle-groupOpen-labelDiagnostic

Summary

This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.

Timeline

Start
2021-06-30
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorocholine Diagnostic / imaging agent 148 mbq
Subject fluorocholine Diagnostic / imaging agent 259 mbq